Skip to main content

Caffeine

ADVERTISEMENT
Identification
Molecular formula
C8H10N4O2
CAS number
58-08-2
IUPAC name
3-isobutyl-1-methyl-7H-purine-2,6-dione
State
State
At room temperature, caffeine exists as a solid. It is commonly processed into a powder form for use in food and pharmaceutical products.
Melting point (Celsius)
235.00
Melting point (Kelvin)
508.15
Boiling point (Celsius)
178.00
Boiling point (Kelvin)
451.15
General information
Molecular weight
194.19g/mol
Molar mass
194.1900g/mol
Density
1.2300g/cm3
Appearence

Caffeine appears as a white, odorless, crystalline solid. It has a bitter taste and is commonly used in various beverages like coffee, tea, and soft drinks. In pure form, it is typically a dry powder.

Comment on solubility

Solubility of 3-isobutyl-1-methyl-7H-purine-2,6-dione (C8H10N4O2)

The solubility of 3-isobutyl-1-methyl-7H-purine-2,6-dione, a purine derivative, can be characterized by several key factors:

  • Polarity: The molecule contains nitrogen and oxygen atoms that can participate in hydrogen bonding, potentially leading to moderate solubility in polar solvents like water.
  • Hydrophobic Character: The presence of the isobutyl and methyl groups introduces hydrophobic characteristics, which can limit solubility in aqueous environments.
  • Solvent Interaction: While it may exhibit reasonable solubility in organic solvents, the extent to which it dissolves can vary based on the specific solvent composition.
  • Temperature Influence: As with many compounds, solubility may increase with temperature, allowing for improved dissolution in both polar and non-polar solvents.

In summary, the solubility of C8H10N4O2 is a balance between its polar and non-polar attributes. As a note, "Like dissolves like," which means that when considering the solubility of this compound, it's essential to match the solvent's nature to the chemical properties of the solute.

Interesting facts

Interesting Facts about 3-Isobutyl-1-methyl-7H-purine-2,6-dione

3-Isobutyl-1-methyl-7H-purine-2,6-dione, often recognized as a derivative of purine, holds intriguing significance in the realm of biochemistry and pharmacology. Here are some captivating aspects to consider:

  • Structural Significance: This compound features a unique structure that is a modified purine ring, which is essential in many biological processes, particularly in the synthesis of nucleotides – the building blocks of DNA and RNA.
  • Biological Activity: Research has indicated that compounds similar to 3-isobutyl-1-methyl-7H-purine-2,6-dione can possess various biological activities, including potential anti-inflammatory effects. Such properties may open the door to therapeutic applications.
  • Role as a Metabolite: It is noteworthy that compounds like this one can act as significant metabolites in various metabolic pathways, influencing how organisms respond to different environmental stimuli.
  • Research Relevance: Ongoing studies are focusing on the synthesis and modification of this compound to better understand its biological interactions and metabolic pathways, highlighting its importance in drug design and development.
  • Chemical Family: The purine derivative family, which includes caffeine and various nucleotides, showcases compounds with varying effects on both human health and plant biology, reflecting the interconnectedness of biochemical compounds.

In the words of renowned biochemist Albert Claude, "The theoretician is the architect of the much more complex structure of matter." This statement resonates well with the intricate designs of compounds like 3-isobutyl-1-methyl-7H-purine-2,6-dione, reminding us that understanding such structures is crucial for global advancements in medicinal and environmental chemistry.


Overall, exploring the nuances of this compound reinforces the rich tapestry of chemistry that connects structure, function, and innovation in scientific progress.

Synonyms
3-Isobutyl-1-methylxanthine
IBMX
28822-58-4
isobutylmethylxanthine
Methylisobutylxanthine
1-METHYL-3-ISOBUTYLXANTHINE
1H-Purine-2,6-dione, 3,7-dihydro-1-methyl-3-(2-methylpropyl)-
Xanthine, 3-isobutyl-1-methyl-
3-isobutyl-1-methylxanthine (ibmx)
3-Isobutyl-1-methyxanthine
3-isobutyl-1-methyl-7H-xanthine
Methyl-isobutylxanthine
3-Isobutyl-1-methyl-1H-purine-2,6(3H,7H)-dione
1-methyl-3-(2-methylpropyl)-7H-purine-2,6-dione
3-Isobutyl-1-methyl-3,7-dihydro-1H-purine-2,6-dione
3-Isobutyl 1-methylxanthine
MFCD00005584
CCRIS 4290
NSC 165960
2-Acetoxy-Benzoic Acid
CHEBI:34795
3-Isobutyl-Methylxanthine
C10H14N4O2
EINECS 249-259-3
3,7-Dihydro-3-isobutyl-1-methyl-1H-purine-2,6-dione
3-isobutyl-1-methyl-3,9-dihydro-1H-purine-2,6-dione
3-Isobutyl-1-methyl-xanthine
TBT296U68M
NSC165960
IBMX (GMP)
1-methyl-3-(2-methylpropyl)-3,7-dihydro-1H-purine-2,6-dione
NSC-165960
SC 2964
CHEMBL275084
DTXSID0040549
1H-purine-2,6-dione, 3,9-dihydro-1-methyl-3-(2-methylpropyl)-
3-ISOBUTHYL-1-METHYLXANTHINE
SC-2964
1-methyl-3-(2-methylpropyl)-3,9-dihydro-1H-purine-2,6-dione
3,7-Dihydro-1-methyl-3-(2-methylpropyl)-1H-purine-2,6-dione
Isobutyltheophylline
3 Isobutyl 1 methylxanthine
IBM
SMR000326697
SR-01000075185
1 Methyl 3 isobutylxanthine
UNII-TBT296U68M
1zkl
1zkn
3ecn
3itu
3jwr
2hd1
2r8q
3qi4
Spectrum2_001705
Spectrum2_001735
Spectrum3_001958
Spectrum4_001052
Spectrum5_001856
Lopac-I-5879
MolMap_000030
IBMX - Bio-X trade mark
3-Isobutyl-1-methylanxthine
Lopac0_000642
Oprea1_135287
Oprea1_228781
SCHEMBL50315
3-isobutyl-1-methylxantliine
BSPBio_001153
BSPBio_003558
GTPL388
KBioGR_000493
KBioGR_001344
KBioGR_002566
KBioSS_000493
KBioSS_002575
1-methyl-3-isobutyl-xanthine
MLS001056732
MLS001066424
DivK1c_000922
SPECTRUM1505298
SPECTRUM2300204
SPBio_001690
SPBio_001810
DTXCID8020549
BCBcMAP01_000110
BDBM15336
CHEBI:43253
CHEBI:48518
HMS502O04
KBio1_000922
KBio2_000493
KBio2_002566
KBio2_003061
KBio2_005134
KBio2_005629
KBio2_007702
KBio3_000905
KBio3_000906
KBio3_002878
KBio3_003044
3-isobutyl-1-methyl-9H-xanthine
cMAP_000087
NINDS_000922
1-methyl-3-(2-methylpropyl)-1,3,7-trihydropurine-2,6-dione
Bio1_000456
Bio1_000945
Bio1_001434
Bio2_000407
Bio2_000887
HMS1362I15
HMS1792I15
HMS1990I15
HMS2090J10
HMS2231C11
HMS3262A05
HMS3369E16
HMS3403I15
HMS3604D14
HMS3648O18
BCP13248
Tox21_500642
BDBM50027176
CCG-39513
CCG-39624
EX-A10290
HB3000
HSCI1_000261
HY-12318G
PDSP1_000324
PDSP2_000322
s5836
STL558248
AKOS003390599
AKOS015903085
CS-3361
DB07954
FI24659
LP00642
SDCCGSBI-0050622.P003
IDI1_000922
IDI1_002162
NCGC00015559-01
NCGC00015559-02
NCGC00015559-03
NCGC00015559-04
NCGC00015559-05
NCGC00015559-06
NCGC00015559-07
NCGC00015559-08
NCGC00015559-09
NCGC00015559-10
NCGC00015559-11
NCGC00015559-21
NCGC00094009-01
NCGC00094009-02
NCGC00094009-03
NCGC00094009-04
NCGC00094009-05
NCGC00094009-06
NCGC00261327-01
Xanthine, 1-methyl-3-(2-methylpropyl)
AS-71134
BI164529
BP-58719
HY-12318
SY074708
3-isobutyl-1-methyl-7H-purine-2,6-dione
DB-047466
[Eur J Pharmacol 170: 35 (1989)]
CS-0626124
EU-0100642
IBMX(NSC165960; SC2964)?
NS00006455
WLN: T56 BM DN FNVNVJ F1Y1&1 H1
3-Isobutyl-1-methyl-2,6(1H,3H)-purinedione
D71221
I 5879
3-Isobutyl-1-methylxanthine, BioUltra, >=99%
L001156
Q223093
3-Isobutyl-1-methylxanthine - CAS 28822-58-4
SR-01000075185-1
SR-01000075185-6
3-Isobutyl-1-methylxanthine, >=99% (HPLC), powder
BRD-K94979336-001-06-9
BRD-K94979336-001-09-3
1H-Purine-2, 3,7-dihydro-1-methyl-3-(2-methylpropyl)-
IMX;Isobutylmethylxanthine;Methylisobutylxanthine;NSC165960;SC2964
1-methyl-3-(2-methylpropyl)-2,3,6,7-tetrahydro-1H-purine-2,6-dione
1-methyl-3-(2-methylpropyl)-2,3,6,9-tetrahydro-1H-purine-2,6-dione
3-isobutyl-1-methyl-7H-xanthine; 3-isobutylmethylxanthine; Xanthine,3-isobutyl-1-methyl
249-259-3
3,9-Dihydro-1-methyl-3-(2-methylpropyl)-1H-purine-2,6-dione;3-Isobutyl-1-methylxanthine;1-Methyl-3-isobutylxanthine
3,9-Dihydro-1-methyl-3-(2-methylpropyl)-1H-purine-2,6-dione;IBMX;1-Methyl-3-isobutylxanthine